You are here

For Journalists

Gladstone welcomes inquiries from journalists. Our media-relations staff is on hand to provide local, regional, national, and international journalists with accurate information about Gladstone’s research and our investigators’ areas of expertise. We are available to arrange interviews with Gladstone scientists and assist in developing story ideas.

Please contact:

Julie Langelier, Science Writer and Public Relations Specialist

Direct line: 415.734.5000

Megan McDevitt, Vice President of Communications
Direct line: 415.734.2019


 

Press Releases

September 23, 2010

SAN FRANCISCO, CA—Scientists at the Gladstone Institute of Neurological Disease (GIND) have uncovered new approaches to reduce toxic proteins in Alzheimer's disease (AD) and other neurodegenerative diseases. The results might lead to new treatments for these diseases.

September 9, 2010

SAN FRANCISCO, CA—Amyloid beta (Αβ) proteins, widely thought to cause Alzheimer's disease, block the transport of vital cargoes inside brain cells.

August 5, 2010

SAN FRANCISCO, CA—Scientists at the Gladstone Institute of Cardiovascular Disease (GICD) have found a new way to make beating heart cells from the body's own cells that could help regenerate damaged hearts.

July 21, 2010

SAN FRANCISCO, CA—The Gladstone Institutes and the international pharmaceutical company H. Lundbeck A/S have announced a collaborative research agreement to study and identify therapeutic candidates for neurological diseases.

July 7, 2010

SAN FRANCISCO, CA—Scientists at the Gladstone Institute of Neurological Disease (GIND) and Stanford University have shown how key circuits in the brain control movement.

June 18, 2010

SAN FRANCISCO, CA—Shinya Yamanaka, MD, PhD, of the Gladstone Institute of Cardiovascular Disease (GICD) and Kyoto University, has won the 2010 Kyoto Prize for Advanced Technology.

June 15, 2010

SAN FRANCISCO, CA—June 15, 2010—The Institute for Systems Biology (ISB) of Seattle, WA, is collaborating with the Gladstone Institute of Neurological Disease (GIND) and its Taube-Koret Center for Huntington's Disease Research to use whole-genome sequencing to identify genes and novel drug targets

April 20, 2010

SAN FRANCISCO, CA—April 20, 2010—Deepak Srivastava, MD, director of the Gladstone Institute of Cardiovascular Disease and Professor of Pediatrics and Biochemistry at UCSF, has been elected to the American Academy of Arts and Sciences. Srivastava joins former Gladstone president Robert W.

March 3, 2010

SAN FRANCISCO—March 3, 2010—With obesity and obesity-related diseases epidemic in the developed world, a clear understanding of how metabolism is regulated is crucial. One of the key metabolic pathways involves the oxidation of fat.

February 18, 2010

SAN FRANCISCO, CA—February 18, 2010—Lennart Mucke, MD, Director of the Gladstone Institute of Neurological Disease (GIND), has been named a recipient of the American Academy of Neurology's prestigious Potamkin Prize.

Pages